Allianz Asset Management
DYN icon

Allianz Asset Management’s Dyne Therapeutics DYN Stock Holding History

Allianz Asset Management’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$593K Buy
26,700
+11,700
+78% +$218K ﹤0.01% 1972
2026
Q1 		$272K Hold
15,000
– – ﹤0.01% 1913
2025
Q4 		$293K Buy
+15,000
New +$284K ﹤0.01% 1902
2025
Q1 		– Sell
-15,800
Closed -$372K – 2246
2024
Q4 		$372K Hold
15,800
– – ﹤0.01% 1948
2024
Q3 		$568K Hold
15,800
– – ﹤0.01% 1817
2024
Q2 		$558K Buy
15,800
+4,000
+34% +$116K ﹤0.01% 1797
2024
Q1 		$335K Buy
+11,800
New +$267K ﹤0.01% 1725

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allianz Asset Management's DYN Position: Q2 2026 in Review

Allianz Asset Management increased its Dyne Therapeutics (DYN) stake by 78% in Q2 2026, buying an estimated $218K and bringing the position to 26,700 shares worth $593K. The position accounts for ﹤0.01% of the portfolio, ranked #1972.

Allianz Asset Management first reported a position in DYN in Q1 2024 and has held it in 7 quarters since. 246 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Allianz Asset Management held 26,700 shares of Dyne Therapeutics worth $593K as of Q2 2026.
  • Allianz Asset Management bought 11,700 Dyne Therapeutics shares in Q2 2026, an estimated $218K.
  • Dyne Therapeutics made up ﹤0.01% of Allianz Asset Management's portfolio in Q2 2026, its #1972 holding.
  • Allianz Asset Management first reported a position in Dyne Therapeutics in Q1 2024 and has held it in 7 quarters since.
  • 246 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.